Overcoming Bottlenecks in Biopharmaceutical Development
Keynote SeriesPharmaceutical Technology and BioPharm International are sponsoring a Keynote Series discussion on bioprocessing challenges on the INTERPHEX 2016 Exhibit Hall Innovation Stage. Admission is free to any attendee with an exhibit hall pass.
Tuesday, April 26, 10:15 am to 11:45 am
Overcoming Bottlenecks in Biopharmaceutical Development
In a panel discussion, industry experts will discuss how technology advances are addressing challenges in biopharmaceutical development including quality control of raw materials, implementation of single-use technologies, process monitoring, and downstream purification.
Panelists:
Marian L. McKee, PhD, Director, US Development Services, MilliporeSigma
Mike Goodwin, Director of R&D, SUT, Thermo Fisher Scientific
Alex Perieteanu, PhD, Director, Biopharmaceutical Services - Life Sciences, SGS Mississauga
Elizabeth Goodrich, Director of Applications Engineering, MilliporeSigma
To register: http://www.interphex.com/pharmtech
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
